MedPath

Comparision of pain relief after total knee replacement surgery between Levobupivacaine(local anaesthetic drug) alone versus Levobupivacaine with Dexmedetomedine(additive)

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2021/10/037439
Lead Sponsor
KIMS MEDICAL COLLEGE
Brief Summary

This study is a randomised single blinded parallel group comparative trial.We intend to compare the duration of post operative pain relief,side effects,total additional analgesic requirement following continuous adductor canal block in post operative patients who have undergone single knee total knee replacement.we would like to compare levobupivacaine o.25% alone versus 0.25% Levobupivacaine with Dexmedetomedine 0.5 microgram per kg body weight.this is a single centre study done in India in a private medical college with a sample size of 40 participants in each group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Patients undergoing elective TKR surgeries 2.
  • Aged between 18 years and 70 years of age 3.
  • American Society of Anesthesiologists (ASA) class 1 to 3.
Exclusion Criteria
  • Allergy to local anaesthetic 2.
  • Intellectual impairment or psychiatric condition precluding adequate communication 3.
  • Bleeding disorder, trauma and infection near the procedure area.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
3.patient satisfaction,24 HOURS
4.Any adverse effects or complications.24 HOURS
PRIMARY-1.Duration of analgesia.24 HOURS
SECONDARY-1.24 hour opioid consumption,24 HOURS
2.success of early ambulation,24 HOURS
Secondary Outcome Measures
NameTimeMethod
SECONDARY-1.24 hour opioid consumption,2.success of early ambulation,

Trial Locations

Locations (1)

KIMS HOSPITAL

🇮🇳

Bangalore, KARNATAKA, India

KIMS HOSPITAL
🇮🇳Bangalore, KARNATAKA, India
KISHORE KEERTHY N
Principal investigator
9739083518
drkishorekeerthy@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.